FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1495581000168106: List of Medicines for Brand Consideration reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Sep 2020. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module
4462321000168116 List of Medicines for Brand Consideration reference set (foundation metadata concept) en Fully specified name Active Initial character case insensitive Third party reference set module
4462331000168118 List of Medicines for Brand Consideration reference set en Synonym Active Initial character case insensitive Third party reference set module
4462411000168119 List of Medicines for Brand Consideration (LMBC) reference set en Synonym Active Initial character case insensitive Third party reference set module
4462641000168118 <p>Supports the identification of AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) that forms part of the Active Ingredient Prescribing initiative. Under the <i>National Health (Pharmaceutical Benefits) Regulations 2017</i>, the <i>Repatriation Pharmaceutical Benefits Scheme Instrument 2013</i> and <i>MRCA Pharmaceutical Benefits Scheme Instrument 2013</i>, all PBS and RPBS prescriptions must be prepared by active ingredient, the brand may additionally be identified if a prescriber considers it necessary. The LMBC supports prescribers' decision-making regarding the inclusion of brand on a prescription.</p><p>This reference set can be used by prescribing software vendors to identify medications for brand consideration to meet Active Ingredient Prescribing requirements.</p><p><b>Target Client:&nbsp;</b>This reference set was developed by the National Clinical Terminology Service for the Australian Government Department of Health and Aged Care to support the Active Ingredient Prescribing initiative, and can be used by developers to assist with the requirements.</p> en Definition Active Case sensitive Third party reference set module


1324 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
List of Medicines for Brand Consideration reference set Is a Reference sets for Medications true Inferred relationship Some
List of Medicines for Brand Consideration reference set Is a Simple type reference set true Inferred relationship Some
List of Medicines for Brand Consideration reference set Developed by Australian Government Department of Health and Aged Care true Inferred relationship Some 1570063879

Members
C1 esterase inhibitor 500 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
C1 esterase inhibitor 500 units injection [2 vials] (&) inert substance diluent [2 x 5 mL vials], 1 pack
C1 esterase inhibitor 500 units injection, vial
agalsidase alfa 3.5 mg/3.5 mL injection, 3.5 mL vial
agalsidase alfa 3.5 mg/3.5 mL injection, vial
agalsidase beta 35 mg injection, 1 vial
agalsidase beta 35 mg injection, vial
amphotericin B (as liposomal) 50 mg injection, 1 vial
amphotericin B (as liposomal) 50 mg injection, 10 vials
amphotericin B (as liposomal) 50 mg injection, vial
amphotericin B 50 mg injection, 1 vial
amphotericin B 50 mg injection, vial
antithymocyte immunoglobulin equine 250 mg/5 mL injection, 5 mL ampoule
antithymocyte immunoglobulin equine 250 mg/5 mL injection, ampoule
antithymocyte immunoglobulin equine 250 mg/5 mL injection, 5 x 5 mL ampoules
antithymocyte immunoglobulin rabbit 25 mg injection, 1 vial
antithymocyte immunoglobulin rabbit 25 mg injection, vial
atropine sulfate monohydrate 1% eye drops
atropine sulfate monohydrate 1% eye drops, 15 mL
atropine sulfate monohydrate 0.01% eye drops, ampoule
atropine sulfate monohydrate 0.01% eye drops, 30 x 0.3 mL ampoules
atropine sulfate monohydrate 0.01% eye drops, 5 x 0.3 mL ampoules
atropine sulfate monohydrate 0.01% eye drops, 60 x 0.3 mL ampoules
atropine sulfate monohydrate 0.01% eye drops, 90 x 0.3 mL ampoules
atropine sulfate monohydrate 1% eye drops, unit dose
atropine sulfate monohydrate 1% eye drops, 20 x 0.5 mL unit doses
beclometasone dipropionate 100 microgram/actuation inhalation, 100 actuations
beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations
beclometasone dipropionate 100 microgram/actuation inhalation, actuation
beclometasone dipropionate 50 microgram/actuation inhalation, 100 actuations
beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations
beclometasone dipropionate 50 microgram / 1 actuation inhalation, actuation (medicinal product unit of use)
beclometasone dipropionate 50 microgram/actuation nasal spray, 100 actuations
beclometasone dipropionate 50 microgram/actuation nasal spray, 2 x 200 actuations
beclometasone dipropionate 50 microgram/actuation nasal spray, 200 actuations
beclometasone dipropionate 50 microgram/actuation nasal spray, actuation
levodopa 50 mg + benserazide 12.5 mg capsule
levodopa 50 mg + benserazide 12.5 mg capsule, 100
levodopa 50 mg + benserazide 12.5 mg dispersible tablet
levodopa 50 mg + benserazide 12.5 mg dispersible tablet, 100
levodopa 100 mg + benserazide 25 mg capsule
levodopa 100 mg + benserazide 25 mg capsule, 100
levodopa 100 mg + benserazide 25 mg dispersible tablet
levodopa 100 mg + benserazide 25 mg dispersible tablet, 100
levodopa 100 mg + benserazide 25 mg modified release capsule
levodopa 100 mg + benserazide 25 mg modified release capsule, 100
levodopa 100 mg + benserazide 25 mg tablet
levodopa 100 mg + benserazide 25 mg tablet, 100
levodopa 200 mg + benserazide 50 mg capsule
levodopa 200 mg + benserazide 50 mg capsule, 100
levodopa 200 mg + benserazide 50 mg tablet
levodopa 200 mg + benserazide 50 mg tablet, 100
betamethasone (as dipropionate) 0.05% cream
betamethasone (as dipropionate) 0.05% cream, 15 g
betamethasone (as dipropionate) 0.05% cream, 2 g
betamethasone (as dipropionate) 0.05% cream, 30 g
betamethasone (as dipropionate) 0.05% cream, 5 g
betamethasone (as dipropionate) 0.05% cream, 50 g
betamethasone (as dipropionate) 0.05% ointment
betamethasone (as dipropionate) 0.05% ointment, 15 g
betamethasone (as dipropionate) 0.05% ointment, 30 g
betamethasone (as dipropionate) 0.05% ointment, 5 g
betamethasone (as dipropionate) 0.05% ointment, 50 g
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack
leuprorelin acetate 7.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack
bimatoprost 0.03% + timolol 0.5% eye drops, unit dose
bimatoprost 0.03% + timolol 0.5% eye drops, 10 x 0.4 mL unit doses
bimatoprost 0.03% + timolol 0.5% eye drops, 30 x 0.4 mL unit doses
bimatoprost 0.03% + timolol 0.5% eye drops, 5 x 0.4 mL unit doses
bimatoprost 0.03% eye drops, unit dose
bimatoprost 0.03% eye drops, 30 x 0.4 mL unit doses
bimatoprost 0.03% eye drops, 5 x 0.4 mL unit doses
bimatoprost 0.03% + timolol 0.5% eye drops
bimatoprost 0.03% + timolol 0.5% eye drops, 3 mL
bimatoprost 0.03% eye drops
bimatoprost 0.03% eye drops, 3 mL
bimatoprost 0.03% eye drops, 3 x 3 mL
botulinum toxin type A 100 units injection, 1 vial
botulinum toxin type A 100 units injection, vial
botulinum toxin type A 200 units injection, 1 vial
botulinum toxin type A 200 mouse LD50 units injection, 200 mouse LD50 units vial (medicinal product unit of use)
botulinum toxin type A 50 units injection, 1 vial
botulinum toxin type A 50 units injection, vial
brimonidine tartrate 0.15% eye drops
brimonidine tartrate 0.15% eye drops, 5 mL
brinzolamide 1% + brimonidine tartrate 0.2% eye drops
brinzolamide 1% + brimonidine tartrate 0.2% eye drops, 5 mL
brimonidine tartrate 0.2% + timolol 0.5% eye drops
brimonidine tartrate 0.2% + timolol 0.5% eye drops, 5 mL
brimonidine tartrate 0.2% eye drops
brimonidine tartrate 0.2% eye drops, 5 mL
brinzolamide 1% + timolol 0.5% eye drops
brinzolamide 1% + timolol 0.5% eye drops, 5 mL
brinzolamide 1% eye drops
brinzolamide 1% eye drops, 10 mL
brinzolamide 1% eye drops, 5 mL
budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, 120 actuations
budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, 60 actuations
budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, actuation
budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, 120 actuations

Page 1 of 14 Next End


Reference Sets

Australian dialect reference set

Reference set descriptor

Back to Start